Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Compared to placebo, the data showed that: Tirzepatide resulted in weight loss of nearly 18% after 72 weeks. Semaglutide produced nearly 14% weight loss after 68 weeks. Retatrutide generated ...

The authors found that individuals on retatrutide (12 mg once-weekly injection) lost 22% of body weight from baseline after 48 weeks. Tirzepatide ... that the greatest loss, aside from retatrutide ...

The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...

On the basis of the clinical trial data, patients on Zepbound (tirzepatide) 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Zepbound’s 10mg weekly dose, the average weight loss ...

Tirzepatide mimics the hormones GLP-1 and GIP, which a person’s stomach produces whenever they eat. These hormones reduce appetite, which can result in weight loss. You must also follow a ...